Drug
Anti-TNF Drug
Anti-TNF Drug is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Completed1
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
completed133%
withdrawn133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruiting
Post-Operative Crohn's Disease Outcome in Children
NCT03681652
withdrawnnot_applicable
Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease
NCT03712826
completed
The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease.
NCT03747068
Clinical Trials (3)
Showing 3 of 3 trials
NCT03681652
Post-Operative Crohn's Disease Outcome in Children
NCT03712826Not Applicable
Identification by Cytometry by Mass of Predictive Immunological Profiles of Answer to Treatmentby Biotherapics for Patients With Crohn's Disease
NCT03747068
The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease.
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3